FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARg in Adipose Tissues

被引:359
作者
Garin-Shkolnik, Tali [1 ]
Rudich, Assaf [2 ]
Hotamisligil, Goekhan S. [3 ]
Rubinstein, Menachem [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
[2] Ben Gurion Univ Negev, Dept Clin Biochem, IL-84105 Beer Sheva, Israel
[3] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA
关键词
ACID-BINDING PROTEIN; ACTIVATED RECEPTOR-GAMMA; METABOLIC SYNDROME; INSULIN-RESISTANCE; GENE-EXPRESSION; VISCERAL ADIPOCYTES; OBESITY; FAT; AP2; ATHEROSCLEROSIS;
D O I
10.2337/db13-0436
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Fatty acid binding protein 4 (FABP4, also known as aP2) is a cytoplasmic fatty acid chaperone expressed primarily in adipocytes and myeloid cells and implicated in the development of insulin resistance and atherosclerosis. Here we demonstrate that FABP4 triggers the ubiquitination and subsequent proteasomal degradation of peroxisome proliferator-activated receptor g (PPARγ), a master regulator of adipogenesis and insulin responsiveness. Importantly, FABP4-null mouse preadipocytes as well as macrophages exhibited increased expression of PPARγ, and complementation of FABP4 in the macrophages reversed the increase in FABP4 expression. The FABP4-null preadipocytes exhibited a remarkably enhanced adipogenesis compared with wild-type cells, indicating that FABP4 regulates adipogenesis by downregulating PPARγ. We found that the FABP4 level was higher and PPARγ level was lower in human visceral fat and mouse epididymal fat compared with their subcutaneous fat. Furthermore, FABP4 was higher in the adipose tissues of obese diabetic individuals compared with healthy ones. Suppression of PPARγ by FABP4 in visceral fat may explain the reported role of FABP4 in the development of obesity-related morbidities, including insulin resistance, diabetes, and atherosclerosis. © 2014 by the American Diabetes Association..
引用
收藏
页码:900 / 911
页数:12
相关论文
共 50 条
[1]
Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site [J].
Adams, M ;
Reginato, MJ ;
Shao, DL ;
Lazar, MA ;
Chatterjee, VK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :5128-5132
[2]
Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor γ agonists in cultured cell [J].
Adida, A ;
Spener, F .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (02) :172-181
[3]
Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes -: Effect of sex and the LIPC promoter variant [J].
Berk-Planken, IIL ;
Hoogerbrugge, N ;
Stolk, RP ;
Bootsma, AH ;
Jansen, H .
DIABETES CARE, 2003, 26 (02) :427-432
[4]
Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis [J].
Boord, JB ;
Fazio, S ;
Linton, MF .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) :141-147
[5]
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[6]
A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis [J].
Chawla, A ;
Boisvert, WA ;
Lee, CH ;
Laffitte, BA ;
Barak, Y ;
Joseph, SB ;
Liao, D ;
Nagy, L ;
Edwards, PA ;
Curtiss, LK ;
Evans, RM ;
Tontonoz, P .
MOLECULAR CELL, 2001, 7 (01) :161-171
[7]
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells [J].
Cipolletta, Daniela ;
Feuerer, Markus ;
Li, Amy ;
Kamei, Nozomu ;
Lee, Jongsoon ;
Shoelson, Steven E. ;
Benoist, Christophe ;
Mathis, Diane .
NATURE, 2012, 486 (7404) :549-U151
[8]
Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[9]
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets [J].
Furuhashi, Masato ;
Hotamisligil, Goekhan S. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) :489-503
[10]
Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice [J].
Furuhashi, Masato ;
Fucho, Raquel ;
Gorgun, Cem Z. ;
Tuncman, Guerol ;
Cao, Haiming ;
Hotamisligil, Goekhan S. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (07) :2640-2650